BIOREM Inc.
BIRMF
$1.90
$0.010.53%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 24.94M | 27.68M | 26.20M | 27.29M | 29.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.94M | 27.68M | 26.20M | 27.29M | 29.61M |
| Cost of Revenue | 18.88M | 20.24M | 19.39M | 19.94M | 20.16M |
| Gross Profit | 6.06M | 7.44M | 6.81M | 7.35M | 9.45M |
| SG&A Expenses | 3.81M | 4.16M | 3.92M | 4.10M | 4.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -29.50K | -24.10K | -24.10K | -24.10K | 5.40K |
| Total Operating Expenses | 22.72M | 24.41M | 23.32M | 24.05M | 24.38M |
| Operating Income | 2.21M | 3.27M | 2.88M | 3.24M | 5.23M |
| Income Before Tax | 2.08M | 3.13M | 2.73M | 3.04M | 5.07M |
| Income Tax Expenses | 555.60K | 832.10K | 727.50K | 807.90K | 1.25M |
| Earnings from Continuing Operations | 1.53 | 2.29 | 2.00 | 2.23 | 3.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.53M | 2.29M | 2.00M | 2.23M | 3.82M |
| EBIT | 2.21M | 3.27M | 2.88M | 3.24M | 5.23M |
| EBITDA | 2.53M | 3.63M | 3.21M | 3.54M | 5.48M |
| EPS Basic | 0.10 | 0.14 | 0.13 | 0.14 | 0.24 |
| Normalized Basic EPS | 0.08 | 0.12 | 0.11 | 0.12 | 0.20 |
| EPS Diluted | 0.06 | 0.10 | 0.08 | 0.10 | 0.21 |
| Normalized Diluted EPS | 0.07 | 0.11 | 0.09 | 0.10 | 0.18 |
| Average Basic Shares Outstanding | 66.28M | 66.07M | 65.74M | 62.80M | 62.90M |
| Average Diluted Shares Outstanding | 71.48M | 71.49M | 71.41M | 70.94M | 72.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |